Taiwan · Delayed Price · Currency is TWD Genovate Biotechnology Statistics
Total Valuation
TPEX:4130 has a market cap or net worth of TWD 3.03 billion. The enterprise value is 1.92 billion.
| Market Cap | 3.03B |
| Enterprise Value | 1.92B |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | Aug 20, 2025 |
Share Statistics
TPEX:4130 has 113.75 million shares outstanding. The number of shares has decreased by -0.65% in one year.
| Current Share Class | 113.75M |
| Shares Outstanding | 113.75M |
| Shares Change (YoY) | -0.65% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 1.29% |
| Float | 49.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.42 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1,670.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 122.14, with an EV/FCF ratio of -52.81.
| EV / Earnings | -209.08 |
| EV / Sales | 4.06 |
| EV / EBITDA | 122.14 |
| EV / EBIT | n/a |
| EV / FCF | -52.81 |
Financial Position
The company has a current ratio of 12.67, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.67 |
| Quick Ratio | 11.24 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | -0.04 |
| Interest Coverage | -27.91 |
Financial Efficiency
Return on equity (ROE) is -0.54% and return on invested capital (ROIC) is -1.93%.
| Return on Equity (ROE) | -0.54% |
| Return on Assets (ROA) | -0.58% |
| Return on Invested Capital (ROIC) | -1.93% |
| Return on Capital Employed (ROCE) | -0.86% |
| Weighted Average Cost of Capital (WACC) | 4.75% |
| Revenue Per Employee | 2.48M |
| Profits Per Employee | -48,242 |
| Employee Count | 190 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.28 |
Taxes
| Income Tax | -987,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.79% in the last 52 weeks. The beta is 0.09, so TPEX:4130's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | +26.79% |
| 50-Day Moving Average | 29.96 |
| 200-Day Moving Average | 25.97 |
| Relative Strength Index (RSI) | 39.46 |
| Average Volume (20 Days) | 176,758 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4130 had revenue of TWD 471.48 million and -9.17 million in losses. Loss per share was -0.08.
| Revenue | 471.48M |
| Gross Profit | 163.03M |
| Operating Income | -17.22M |
| Pretax Income | -10.15M |
| Net Income | -9.17M |
| EBITDA | 17.16M |
| EBIT | -17.22M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 1.11 billion in cash and 1.57 million in debt, with a net cash position of 1.11 billion or 9.75 per share.
| Cash & Cash Equivalents | 1.11B |
| Total Debt | 1.57M |
| Net Cash | 1.11B |
| Net Cash Per Share | 9.75 |
| Equity (Book Value) | 1.99B |
| Book Value Per Share | 17.51 |
| Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was 1.81 million and capital expenditures -38.10 million, giving a free cash flow of -36.29 million.
| Operating Cash Flow | 1.81M |
| Capital Expenditures | -38.10M |
| Depreciation & Amortization | 34.38M |
| Net Borrowing | -981,000 |
| Free Cash Flow | -36.29M |
| FCF Per Share | -0.32 |
Margins
Gross margin is 34.58%, with operating and profit margins of -3.65% and -1.94%.
| Gross Margin | 34.58% |
| Operating Margin | -3.65% |
| Pretax Margin | -2.15% |
| Profit Margin | -1.94% |
| EBITDA Margin | 3.64% |
| EBIT Margin | -3.65% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.37%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.37% |
| Dividend Growth (YoY) | -32.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.65% |
| Shareholder Yield | 1.02% |
| Earnings Yield | -0.30% |
| FCF Yield | -1.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 20, 2025. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 20, 2025 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |